{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T19:31:47Z","timestamp":1787254307561,"version":"build-2736575974"},"reference-count":20,"publisher":"American Diabetes Association","issue":"9","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"DOI":"10.2337\/dci26-0084","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T19:08:04Z","timestamp":1787252884000},"page":"1554-1556","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":0,"title":["Beyond Glycemia: Entering the Era of Hard Outcomes for Continuous Glucose Monitoring"],"prefix":"10.2337","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7030-0442","authenticated-orcid":false,"given":"Wajd","family":"Alkabbani","sequence":"first","affiliation":[{"name":"School of Pharmacy, University of Waterloo 1 , Kitchener, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4924-2049","authenticated-orcid":false,"given":"Sara J.","family":"Cromer","sequence":"additional","affiliation":[{"name":"Diabetes Unit, Massachusetts General Hospital and Harvard Medical School 2 , Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8809-9898","authenticated-orcid":false,"given":"Elisabetta","family":"Patorno","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine & Health Services Research, Department of Medicine, David Geffen School of Medicine at UCLA 3 , Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"2026082015061326400_B1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jama.2016.19975","article-title":"Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial","volume":"317","author":"Beck","year":"2017","journal-title":"JAMA"},{"key":"2026082015061326400_B2","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time in Range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"2026082015061326400_B3","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1001\/jama.2020.6928","article-title":"Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial","volume":"323","author":"Pratley","year":"2020","journal-title":"JAMA"},{"key":"2026082015061326400_B4","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1001\/jama.2021.7444","article-title":"Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial","volume":"325","author":"Martens","year":"2021","journal-title":"JAMA"},{"key":"2026082015061326400_B5","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1001\/jama.2021.6530","article-title":"Association of real-time continuous glucose monitoring with glycemic control and acute metabolic events among patients with insulin-treated diabetes","volume":"325","author":"Karter","year":"2021","journal-title":"JAMA"},{"key":"2026082015061326400_B6","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1007\/s00125-026-06709-2","article-title":"Continuous glucose monitoring and risks of acute and chronic diabetes-related complications and mortality in adults with type 1 diabetes: a nationwide cohort study","volume":"69","author":"Kim","year":"2026","journal-title":"Diabetologia"},{"key":"2026082015061326400_B7","doi-asserted-by":"crossref","first-page":"1589\u20131598","DOI":"10.2337\/dc26-0425","article-title":"Continuous glucose monitoring initiation is associated with reduced mortality in older-onset type 1 diabetes patients: a target trial emulation study within the Veterans Health Administration","volume":"49","author":"Reaven","year":"2026","journal-title":"Diabetes Care"},{"key":"2026082015061326400_B8","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2337\/dc22-2189","article-title":"Initiation of continuous glucose monitoring is linked to improved glycemic control and fewer clinical events in type 1 and type 2 diabetes in the Veterans Health Administration","volume":"46","author":"Reaven","year":"2023","journal-title":"Diabetes Care"},{"key":"2026082015061326400_B9","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.2337\/dc24-0690","article-title":"Initiation of intermittently scanned continuous glucose monitoring is associated with reduced hospitalization for acute diabetes events and cardiovascular complications in adults with type 1 diabetes","volume":"47","author":"Eeg-Olofsson","year":"2024","journal-title":"Diabetes Care"},{"key":"2026082015061326400_B10","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1001\/jama.2022.21383","article-title":"Target trial emulation: a framework for causal inference from observational data","volume":"328","author":"Hern\u00e1n","year":"2022","journal-title":"JAMA"},{"key":"2026082015061326400_B11","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/endrev\/bnab007","article-title":"Conducting real-world evidence studies on the clinical outcomes of diabetes treatments","volume":"42","author":"Schneeweiss","year":"2021","journal-title":"Endocr Rev"},{"key":"2026082015061326400_B12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrrheum.2015.30","article-title":"Active-comparator design and new-user design in observational studies","volume":"11","author":"Yoshida","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"2026082015061326400_B13","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2337\/dc12-0964","article-title":"Automated detection and classification of type 1 versus type 2 diabetes using electronic health record data","volume":"36","author":"Klompas","year":"2013","journal-title":"Diabetes Care"},{"key":"2026082015061326400_B14","unstructured":"Hirsch\n              IB\n            , PihokerC, RobertsA, . Medication use and self-care practices in persons with diabetes. Diabetes in America, 2024. Accessed 6 July 2026. Available from https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK607283\/"},{"key":"2026082015061326400_B15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2337\/cd23-0051","article-title":"Patterns and trends in continuous glucose monitoring utilization among commercially insured individuals with type 1 diabetes: 2010-2013 to 2016-2019","volume":"42","author":"Lacy","year":"2024","journal-title":"Clin Diabetes"},{"key":"2026082015061326400_B16","doi-asserted-by":"crossref","first-page":"e2526353","DOI":"10.1001\/jamanetworkopen.2025.26353","article-title":"Trends and disparities in technology use and glycemic control in type 1 diabetes","volume":"8","author":"Fang","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026082015061326400_B17","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1089\/dia.2020.0338","article-title":"Racial-ethnic disparities in diabetes technology use among young adults with type 1 diabetes","volume":"23","author":"Agarwal","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2026082015061326400_B18","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1111\/dom.15774","article-title":"Systematic review of disparities in continuous glucose monitoring and insulin pump utilization in the United States: key themes and evidentiary gaps","volume":"26","author":"Patel","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2026082015061326400_B19","doi-asserted-by":"crossref","first-page":"e2516523","DOI":"10.1001\/jamanetworkopen.2025.16523","article-title":"Language disparities in continuous glucose monitoring for type 2 diabetes","volume":"8","author":"Rodriguez","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026082015061326400_B20","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2337\/dca25-0006","article-title":"Overall uptake and racial, ethnic, and socioeconomic disparities in the use of continuous glucose monitoring devices among insulin-treated older adults with type 2 diabetes","volume":"48","author":"Alkabbani","year":"2025","journal-title":"Diabetes Care"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/9\/1554\/893316\/dci260084.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/9\/1554\/893316\/dci260084.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T19:08:06Z","timestamp":1787252886000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/49\/9\/1554\/172345\/Beyond-Glycemia-Entering-the-Era-of-Hard-Outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":20,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,8,20]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dci26-0084","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]}}}